An Adaptive Treatment Strategy for Adolescent Depression
| Status: | Recruiting |
|---|---|
| Conditions: | Depression |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 12 - 17 |
| Updated: | 4/21/2016 |
| Start Date: | November 2010 |
| End Date: | November 2016 |
| Contact: | Ana Westervelt, BA |
| Email: | bortn005@umn.edu |
| Phone: | 6126267065 |
The purpose of the study is:
1. to find out how long teenagers getting talk therapy (interpersonal psychotherapy) for
depression should get therapy before the therapist decides whether or not the teenager
is improving enough, and
2. to compare two ways of providing treatment to teenagers who have not improved enough.
1. to find out how long teenagers getting talk therapy (interpersonal psychotherapy) for
depression should get therapy before the therapist decides whether or not the teenager
is improving enough, and
2. to compare two ways of providing treatment to teenagers who have not improved enough.
Study Procedures
This study has three phases:
1. The screening and eligibility phase:
Parent and child will conduct an initial evaluation that will last about 4 hours. The
evaluator will ask questions and the participant will complete forms about his/her mood
and behavior. This intake appointment will determine eligibility for the study.
2. The treatment phase: The child would begin a kind of talk therapy called interpersonal
psychotherapy. The goal of the therapy is to decrease teenagers' depression by helping
them improve their relationships and communication skills. The child will attend 12
therapy appointments over the course of 16 weeks. Each appointment will be 50 minutes
long.
If the child is doing well with standard interpersonal therapy, it will be continued
without change. If the child has not improved enough, we will change the treatment plan
in one of two ways. The choice will be based on chance (sort of like flipping a coin)
and will be done by a computer.
***Your child will attend 16 therapy appointments (that is four additional sessions).
These additional four sessions will be scheduled so that your child will attend therapy
twice a week for a period of four weeks.
-OR-
***Your child will continue to attend 12 therapy appointments over the course of 16
weeks and your child will also be prescribed an antidepressant medication called
fluoxetine. Fluoxetine is also known as Prozac. Prozac has been approved by the Food
and Drug Administration for use in the treatment of depressed teenagers. You will be
responsible for paying for the medication.
At four points during the treatment phase (week 4, week 8, week 12, and week 16),
parent and child will be asked to complete forms and interviews to see how the child is
doing. The evaluations at weeks 4, 8, and 12 will take approximately 1 hour. At the end
of treatment, parent and child will have a longer meeting with the evaluator (4 hours)
to see if the treatment your child got was helpful. During these meetings, we will also
ask participants to fill out some forms about your mood and mental health treatment.
3. The follow-up phase: Parent and child will be asked to return for a follow-up
assessment 4 months after the child completes the treatment phase to see how he or she
is doing. Parent and child will be asked to complete forms and interviews. This meeting
will take approximately 4 hours.
This study has three phases:
1. The screening and eligibility phase:
Parent and child will conduct an initial evaluation that will last about 4 hours. The
evaluator will ask questions and the participant will complete forms about his/her mood
and behavior. This intake appointment will determine eligibility for the study.
2. The treatment phase: The child would begin a kind of talk therapy called interpersonal
psychotherapy. The goal of the therapy is to decrease teenagers' depression by helping
them improve their relationships and communication skills. The child will attend 12
therapy appointments over the course of 16 weeks. Each appointment will be 50 minutes
long.
If the child is doing well with standard interpersonal therapy, it will be continued
without change. If the child has not improved enough, we will change the treatment plan
in one of two ways. The choice will be based on chance (sort of like flipping a coin)
and will be done by a computer.
***Your child will attend 16 therapy appointments (that is four additional sessions).
These additional four sessions will be scheduled so that your child will attend therapy
twice a week for a period of four weeks.
-OR-
***Your child will continue to attend 12 therapy appointments over the course of 16
weeks and your child will also be prescribed an antidepressant medication called
fluoxetine. Fluoxetine is also known as Prozac. Prozac has been approved by the Food
and Drug Administration for use in the treatment of depressed teenagers. You will be
responsible for paying for the medication.
At four points during the treatment phase (week 4, week 8, week 12, and week 16),
parent and child will be asked to complete forms and interviews to see how the child is
doing. The evaluations at weeks 4, 8, and 12 will take approximately 1 hour. At the end
of treatment, parent and child will have a longer meeting with the evaluator (4 hours)
to see if the treatment your child got was helpful. During these meetings, we will also
ask participants to fill out some forms about your mood and mental health treatment.
3. The follow-up phase: Parent and child will be asked to return for a follow-up
assessment 4 months after the child completes the treatment phase to see how he or she
is doing. Parent and child will be asked to complete forms and interviews. This meeting
will take approximately 4 hours.
Inclusion Criteria:
- Adolescent meets DSM-IV-TR criteria for a diagnosis of Major Depressive Disorder,
Dysthymia, or Depressive Disorder NOS; demonstrate symptoms of depression (CDRS-R >
35); and demonstrate impairment in general functioning (CGAS < 65).
- Adolescents and parents must be English-speaking
Exclusion Criteria:
- Adolescent meets criteria for a diagnosis of Schizophrenia, Bipolar Disorder,
Psychosis, Substance Abuse, OCD, Conduct Disorder, Eating Disorder, PDD, or Mental
Retardation.
- Depressed adolescents who are actively suicidal with a plan and/or intent
- Adolescent that are already receiving treatment for depression or if they are taking
medication for a psychiatric diagnosis other than ADHD. Depressed adolescents with a
comorbid diagnosis of ADHD who are on a stable dose of stimulant medication (> 3
months) will be eligible to participate in the studies.
- Adolescent that have already received an adequate trial of IPT-A or fluoxetine.
- Female adolescents who are pregnant, breastfeeding, or having unprotected sexual
intercourse.
We found this trial at
1
site
Click here to add this to my saved trials
